BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14945781)

  • 1. [Effects of nucleic acids alone and in combination with the heart glycoside convallatoxin on the isolated frog heart].
    FISCHER H; LANGEMANN H
    Helv Physiol Pharmacol Acta; 1951 Dec; 9(4):406-15. PubMed ID: 14945781
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experience with the purified glycoside convallatoxin].
    WEISE H; ESSER H
    Med Klin; 1956 Mar; 51(11):432-3. PubMed ID: 13308774
    [No Abstract]   [Full Text] [Related]  

  • 3. [Quantitative relationship of strophantoside effect on frog heart to cardiac activity and glycoside concentration].
    WILBRANDT W; BRAWAND K; WITT PN
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1953; 219(5):397-407. PubMed ID: 13099376
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of previous or simultaneous application of cocarboxylase, ribonuclease, pyruvic acid and quinine on the response of the isolated frog heart to convallatoxin].
    LIU KT
    Arch Int Pharmacodyn Ther; 1951 Sep; 87(4):439-58. PubMed ID: 14895205
    [No Abstract]   [Full Text] [Related]  

  • 5. [ON THE COMPARATIVE ACTION OF CORCHOROZIDE AND CONVALLATOXIN IN ACUTE CORONARY INSUFFICIENCY].
    PROVOTOROVA PP
    Farmakol Toksikol; 1963; 26():284-8. PubMed ID: 14051662
    [No Abstract]   [Full Text] [Related]  

  • 6. [ON STRUCTURE-EFFECT RELATIONS IN CARDINOLIDES AND BUFADIENOLIDES. IV. COMPARISON OF THE EFFECT OF A METHYL-, ALDEHYDE- AND CARBINOL SUBSTITUTION OF THE C10-ATOM OF CARDENOLIDES. CONTRIBUTION TO THE PHARMACOLOGY OF CONVALLATOXIN].
    FOERSTER W
    Acta Biol Med Ger; 1963; 11():234-45. PubMed ID: 14064783
    [No Abstract]   [Full Text] [Related]  

  • 7. [The convallatoxin in its relation to the heart glycosides and to the right insufficiency of the heart].
    UHLENBRUCK P; SCHMITZ W
    Dtsch Med Wochenschr; 1954 Nov; 79(46):1718-22. PubMed ID: 13220160
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of corglycon on the cardiovascular system].
    ANGARSKAIA MA; GENDENSHTEIN EI
    Farmakol Toksikol; 1956; 19(5):34-8. PubMed ID: 13384466
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of two rapid acting cardiac glycosides on dog's heart-lung preparation.
    ARESKOG NH
    Acta Physiol Scand; 1962; 55():139-49. PubMed ID: 13862171
    [No Abstract]   [Full Text] [Related]  

  • 10. [Convallatoxin treatment of severe heart insufficiency].
    WALZ L; MAIDHOF E
    Medizinische; 1955 Jun; 23():845-50. PubMed ID: 13244144
    [No Abstract]   [Full Text] [Related]  

  • 11. [ON THE ACUTE AND SUBACUTE TOXICITY OF CONVALLATOXOL IN COMPARISON WITH CONVALLATOXIN AND G-STROPHANTHIN].
    FOERSTER W; SZIEGOLEIT W
    Acta Biol Med Ger; 1964; 12():434-42. PubMed ID: 14134947
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative evaluation of the treatment of circulatory insufficiency with Lantoside, Erysimine, Corglycon and Strophanthin].
    MATOSIANTS AI
    Med Zh Uzb; 1962 May; 5():35-40. PubMed ID: 14471203
    [No Abstract]   [Full Text] [Related]  

  • 13. [Glucosides from thrush; convallatoxin (Convallaria majalis L.) (Liliacese)].
    LUTEMBACHER R; DE LUNA J
    Bull Med; 1947 Nov; 61(32):453-60. PubMed ID: 18899074
    [No Abstract]   [Full Text] [Related]  

  • 14. [New glycoside preparation from Convallaria majalis leaves in the treatment of circulatory insufficiency].
    SHUBOV MI
    Ter Arkh; 1951; 23(2):59-62. PubMed ID: 14855404
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid detection of the active cardiac glycoside convallatoxin of lily of the valley using LOCI digoxin assay.
    Welsh KJ; Huang RS; Actor JK; Dasgupta A
    Am J Clin Pathol; 2014 Sep; 142(3):307-12. PubMed ID: 25125619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CONVALLATOXIN THERAPY OF COR PULMONALE IN CHRONIC EMPHYSEMA BRONCHITIS].
    MUELLER JH
    Z Arztl Fortbild (Jena); 1963 Dec; 57():1290-2. PubMed ID: 14112843
    [No Abstract]   [Full Text] [Related]  

  • 17. [A CONTRIBUTION TO ORAL CONVALLARIA-GLYCOSIDE THERAPY].
    MUELLER J
    Med Monatsschr; 1964 Apr; 18():177-9. PubMed ID: 14212368
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of oxyphylline on the cardiotoxic activity of convallatoxin and helveticoside and on their action on the heart-lung preparation of the cat].
    DITTERTOVA V; BURAN L; BABULOVA A; SELECKY FV
    Cesk Farm; 1963 Feb; 12():104-7. PubMed ID: 14028075
    [No Abstract]   [Full Text] [Related]  

  • 19. Convallatoxin, the primary cardiac glycoside in lily of the valley (Convallaria majalis), induces tissue factor expression in endothelial cells.
    Morimoto M; Tatsumi K; Yuui K; Terazawa I; Kudo R; Kasuda S
    Vet Med Sci; 2021 Nov; 7(6):2440-2444. PubMed ID: 34469053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of native Convallaria glycoside in the therapy of cardiac insufficiency in practice].
    NIEDNER R
    Med Welt; 1960 May; 20():1108-11. PubMed ID: 14427072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.